These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7905376)

  • 1. Tolerability of levocabastine eye drops.
    Janssens M; Blockhuys S
    Doc Ophthalmol; 1993; 84(2):111-8. PubMed ID: 7905376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of twice-daily emedastine 0.05% eye drops (Emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis.
    Verin P; Easty DL; Secchi A; Ciprandi G; Partouche P; Nemeth-Wasmer G; Brancato R; Harrisberg CJ; Estivin-Ebrardt C; Coster DJ; Apel AJ; Coroneo MT; Knorr M; Carmichael TR; Kent-Smith BT; Abrantes P; Leonardi A; Cerqueti PM; Modorati G; Martinez M
    Am J Ophthalmol; 2001 Jun; 131(6):691-8. PubMed ID: 11384563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical levocabastine compared with orally administered terfenadine for the prophylaxis and treatment of seasonal rhinoconjunctivitis.
    Søhoel P; Freng BA; Kramer J; Poppe S; Rebo R; Korsrud FR; Garud O; Woxen OJ; Olsen AK
    J Allergy Clin Immunol; 1993 Jul; 92(1 Pt 1):73-81. PubMed ID: 8101534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levocabastine eye drops: a new approach for the treatment of acute allergic conjunctivitis.
    Abelson MB; Weintraub D
    Eur J Ophthalmol; 1994; 4(2):91-101. PubMed ID: 7950341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid onset of action of levocabastine eye-drops in histamine-induced conjunctivitis.
    Stokes TC; Feinberg G
    Clin Exp Allergy; 1993 Sep; 23(9):791-4. PubMed ID: 10779311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New trends in the treatment of allergic conjunctivitis.
    Parys W; Blockhuys S; Janssens M
    Doc Ophthalmol; 1992; 82(4):353-60. PubMed ID: 1363981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of topical levocabastine compared with oral terfenadine.
    Bahmer FA; Ruprecht KW
    Ann Allergy; 1994 May; 72(5):429-34. PubMed ID: 7909999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of topical levocabastine and oral terfenadine in the treatment of allergic rhinoconjunctivitis. The Livostin Study Group.
    Allergy; 1993 Oct; 48(7):530-4. PubMed ID: 7902024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical levocabastine compared with oral loratadine for the treatment of seasonal allergic rhinoconjunctivitis. Swedish GP Allergy Team.
    Allergy; 1994 Sep; 49(8):611-5. PubMed ID: 7653738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of azelastine eye drops with levocabastine eye drops in the treatment of seasonal allergic conjunctivitis.
    Giede C; Metzenauer P; Petzold U; Ellers-Lenz B
    Curr Med Res Opin; 2000; 16(3):153-63. PubMed ID: 11191004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emedastine ophthalmic solution 0.05% versus levocabastine ophthalmic suspension 0.05% in the treatment of allergic conjunctivitis using the conjunctival allergen challenge model.
    Netland PA; Leahy C; Krenzer KL
    Am J Ophthalmol; 2000 Dec; 130(6):717-23. PubMed ID: 11124289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of ophthalmic epinastine: a randomized, double-masked, parallel-group, active- and vehicle-controlled environmental trial in patients with seasonal allergic conjunctivitis.
    Whitcup SM; Bradford R; Lue J; Schiffman RM; Abelson MB
    Clin Ther; 2004 Jan; 26(1):29-34. PubMed ID: 14996515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levocabastine: a new topical approach for the treatment of paediatric allergic rhinoconjunctivitis.
    Janssens MM
    Rhinol Suppl; 1992 Sep; 13():39-49. PubMed ID: 1358140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antazoline/tetryzoline eyedrops in comparison with levocabastine eyedrops in acute allergic conjunctivitis].
    Wertheimer R; Blessmann G
    Klin Monbl Augenheilkd; 1997 Feb; 210(2):93-6. PubMed ID: 9229602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levocabastine eye drops in the treatment of vernal conjunctivitis.
    Goes F; Blockhuys S; Janssens M
    Doc Ophthalmol; 1994; 87(3):271-81. PubMed ID: 7835196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multicenter evaluation of a new local antihistaminic drug (levocabastine)].
    Bischoff P; Gerber M
    Klin Monbl Augenheilkd; 1992 May; 200(5):354-7. PubMed ID: 1351957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical levocabastine is more effective than sodium cromoglycate for the prophylaxis and treatment of seasonal allergic conjunctivitis.
    Davies BH; Mullins J
    Allergy; 1993 Oct; 48(7):519-24. PubMed ID: 7902022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical levocabastine--an effective alternative to oral antihistamines in seasonal allergic rhinoconjunctivitis.
    Bahmer FA
    Clin Exp Allergy; 1995 Mar; 25(3):220-7. PubMed ID: 7788568
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of the new ophthalmic antihistamine, 0.05% levocabastine, in the clinical allergen challenge model of allergic conjunctivitis.
    Abelson MB; George MA; Schaefer K; Smith LM
    J Allergy Clin Immunol; 1994 Sep; 94(3 Pt 1):458-64. PubMed ID: 7916020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind comparison of levocabastine eye drops with sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis.
    Azevedo M; Castel-Branco MG; Oliveira JF; Ramos E; Delgado L; Almeida J
    Clin Exp Allergy; 1991 Nov; 21(6):689-94. PubMed ID: 1685691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.